The partnership gives Ajman University students access to three major healthcare facilities: Sheikh Khalifa General Hospital in Umm Al Quwain, Sheikh Khalifa Specialty Hospital in Ras Al Khaimah, and Sheikh Khalifa Medical City in Ajman.
In sub-Saharan Africa, untreated jaundice-related complications responsible for up to 80 percent of neonatal deaths.
The center emerged from a strategic partnership between the Burjeel Cancer Institute and the Neuroscience Institute at BMC, bringing together a multidisciplinary team of leading specialists.
The new facility adds to Tajmeel’s growing portfolio of over 30 specialized treatments spanning beauty, regenerative medicine, and surgical transformation.
A core focus of the partnership is building stronger capabilities among eye care professionals, whereby the two organizations will develop and launch specialized training programs designed for doctors and healthcare practitioners working in ophthalmology.
The hospital will roll out in four phases covering technical planning, project management, commissioning, and full operational launch under Apollo’s brand.
The Intracept™ Procedure targets the basivertebral nerve, which carries pain signals from damaged vertebral endplates.
The IMARA–BC initiative targets women aged 40 and above, encouraging them to undergo routine screening so that cancer is detected at stage one or two, when treatment is most effective.
The new facility operates as a fully smart, digital-first outpatient center that connects appointments, consultations, diagnostics, pharmacy services, and follow-up care through integrated digital systems.
The partnership will provide JOOTRH with dedicated advanced facilities, including project-specific space for an Advanced Pathology Lab within the hospital.